“Global spending on prescription medicines will accelerate next year to exceed $1 trillion for the first time, fueled by the launch of more innovative drugs and rising health expenditure in emerging markets led by China,” the Financial Times reports. The projections were made by the IMS Institute for Healthcare Informatics, according to the newspaper. “Two-thirds of the total medicines market in 2017 will be accounted for by the eight markets of the U.S., France, Germany, the U.K., Italy and Spain, as well as China and Japan, which will also be responsible for nearly 60 percent of the total growth in spending,” the newspaper writes (Jack, 11/19).